このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。英語版ソーステキスト用。

Questionnaire Study Concerning Artificial Intelligence

2022年2月3日更新者：Maastricht University Medical Center

Questionnaire Study Concerning Artificial Intelligence and Its Application in (Gastrointestinal) Healthcare - Patients' and Physicians' Perspectives

This study aims to investigate the knowledge, experience, and opinion on AI among gastroenterology (GI) patients, gastroenterologists, and GI-fellows, particularly concerning implementation and application of AI (in assisting clinicians) in healthcare. The secondary aims are to investigate (dis)advantages of AI use in healthcare and the availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.

調査の概要

状態

完了

条件

胃腸疾患

介入・治療

他の：Questionnaire

詳細な説明

In recent years, important developments have been made in the field of artificial intelligence (AI). These developments have led to the large-scale application of AI in our everyday lives and AI-research within healthcare. A potentially promising application of AI lies in imaging analysis. For example, within gastroenterology this means the detection and classification of colorectal polyps and Barrett's neoplasia, disease severity scoring of inflammatory bowel diseases, and differentiating pancreatic cancer from chronic pancreatitis.

Despite the investments in AI-research, there is a lack in knowledge concerning patients' and physicians' perspectives on AI in healthcare. This prospective questionnaire study investigates these perspectives, obtaining data from both gastroenterology (GI) patients and GI-physicians within the Netherlands. The questionnaires focus on the knowledge, experience, and opinion of AI, particularly concerning the implementation of AI in (gastroenterology) healthcare. Furthermore, the current (endoscopic) infrastructure within Dutch hospitals will be investigated for its readnessy for AI.

研究の種類

観察的

入学 (実際)

457

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

オランダ
- Limburg
  - Maastricht、Limburg、オランダ、6202AZ
    - Maastricht University Medical Center
- Noord-Brabant
  - Eindhoven、Noord-Brabant、オランダ、5623 EJ
    - Catharina Ziekenhuis Eindhoven

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

Gastroenterology patients who will have an outpatient appointment for an endoscopic procedure in the context of the national bowel cancer screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases, in one of two Dutch hospitals between April 2020 and September 2020.

Gastroenterologists and gastroenterology fellows working in Dutch hospitals.

説明

Inclusion Criteria:

Gastrointestinal (GI) patients with an outpatient appointment in the gastroenterology department for an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases (in one of the two participating hospitals);
Gastroenterologists working in Dutch hospitals;
Gastroenterology fellows working in Dutch hospitals;
Minimal age of 18 years old.

Exclusion Criteria:

No appropriate understanding of the Dutch language;
Not willing to sign informed consent;
Objection to participate in medical scientific research, reported in the medical file.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか？

デザインの詳細

グループ/コホートの数

コホートと介入

グループ/コホート	介入・治療
Gastroenterology patients Patient receiving an endoscopic procedure because of regular care will be considered eligible for inclusion. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases. Patients will be asked to complete a questionnaire concerning AI. No intervention will be administered.	他の：Questionnaire Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.
Gastroenterology physicians GI physicians (both gastroenterologists and gastroenterology fellows), participating in a yearly gastroenterology and hepatology training day, will be asked for their participation in this study. Physician will be asked to complete a questionnaire concerning AI. No intervention will be administered.	他の：Questionnaire Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.

グループ/コホート

介入・治療

Gastroenterology patients

Patient receiving an endoscopic procedure because of regular care will be considered eligible for inclusion. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases.

Patients will be asked to complete a questionnaire concerning AI. No intervention will be administered.

他の：Questionnaire

Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.

Gastroenterology physicians

GI physicians (both gastroenterologists and gastroenterology fellows), participating in a yearly gastroenterology and hepatology training day, will be asked for their participation in this study.

Physician will be asked to complete a questionnaire concerning AI. No intervention will be administered.

他の：Questionnaire

Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.

この研究は何を測定していますか？

主要な結果の測定

結果測定	メジャーの説明	時間枠
The knowledge on AI investigated by means of a questionnaire 時間枠：6 months	The knowledge on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.	6 months
The experience with AI investigated by means of a questionnaire 時間枠：6 months	The experience with AI (in healthcare) among gastroenterology patients and physicians, investigated by means of a questionnaire.	6 months
The opinion on AI investigated by means of a questionnaire 時間枠：6 months	The oninion on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.	6 months

二次結果の測定

結果測定	メジャーの説明	時間枠
Willingness of physicians to use AI in (gastroenterology) healthcare 時間枠：6 months	The willingness to apply AI in (gastroenterology) healthcare among gastroenterology physicians.	6 months
Willingness to apply AI in (gastroenterology) healthcare 時間枠：6 months	The willingness of gastroenterology patients for their physicians to apply AI in (gastroenterology) healthcare.	6 months
Advantages and disadvantages of AI use in (gastroenterology) healthcare 時間枠：6 months	Important advantages and disadvantages of AI use in (gastroenterology) healthcare among gastroenterology patients and physicians.	6 months
Potential domains within gastroenterology and hepatology for AI use 時間枠：6 months	Potential domains within gastroenterology and hepatology for AI use indicated by GI physicians.	6 months
Mandatory infrastructure for AI use in healthcare 時間枠：6 months	The availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.	6 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

Maastricht University Medical Center

協力者

Catharina Ziekenhuis Eindhoven

捜査官

主任研究者：Ad Masclee, Prof Dr MD、Maastricht Universitair Medisch Centrum

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2020年4月8日

一次修了 (実際)

2021年8月12日

研究の完了 (実際)

2021年8月12日

試験登録日

最初に提出

2022年1月13日

QC基準を満たした最初の提出物

2022年1月26日

最初の投稿 (実際)

2022年1月31日

学習記録の更新

投稿された最後の更新 (実際)

2022年2月18日

QC基準を満たした最後の更新が送信されました

2022年2月3日

最終確認日

2022年2月1日

詳しくは

本研究に関する用語

キーワード

追加の関連 MeSH 用語

その他の研究ID番号

METC 2020-2281

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

Data collected for the study, including individual participant data, will be made available upon request. This data includes deidentified participant data. Additional documents that will be made available are the study protocol, the statistical analysis plan, the questionnaires, and the informed consent forms. Data will be available following publication with no end date. Requests should be methodologically sound proposals with the purpose to achieve aims in the approved proposal. Researchers who request the data should direct the proposal to q.vanderzander@maastrichtuniversity.nl to gain access. Data requestors will need to sign a data access agreement after approval of a proposal.

IPD 共有時間枠

Data will be available following publication with no end date.

IPD 共有アクセス基準

Requests should be methodologically sound proposals with the purpose to achieve aims in the approved proposal. Data requestors will need to sign a data access agreement after approval of a proposal.

IPD 共有サポート情報タイプ

STUDY_PROTOCOL
SAP
ICF

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

Questionnaire Study Concerning Artificial Intelligence